Print

Ellinghorst IR compiles independent consensus forecasts of UCB based on the financial estimates of various analysts covering UCB.

In order to provide meaningful data only regularly updated or reiterated estimates are included in the consensus. The tables below are based on the estimates of almost 20 different brokers. See the list of analysts and their contact details here

If you wish to be informed whenever we have updated consensus, simply send an e-mail to This email address is being protected from spambots. You need JavaScript enabled to view it. quoting "consensus email alert" as subject.  

 ucb

UCB HY 2018 Consensus 

In € million HY 2018E
Average
HY 2018E
Median
Cimzia 663 657
Vimpat 499 498
Neupro 154 154
Briviact 65 66
Keppra 377 377
Revenue 2,186 2,170
REBIT 548 546
REBITDA 670 666
Net Profit  378 386
Core EPS 2.26 2.26

UCB FY Consensus Product Sales Estimates (Average)

In € million 2017a 2018e 2019e 2020e  2021e  2022e  2023e
Cimzia 1,424 1,449 1,486 1,498 1,488 1,448 1,431
Vimpat 976 1,053 1,166 1,268 1,367 1,081 754
Neupro 314 328 343 353 318 274 233
Briviact 87 159 228 291 351 402 456
Keppra 778 750 696 656 605 565 518

 

UCB FY Consensus Earnings Estimates (Average)

In € million 2017a 2018e 2019e 2020e 
Net Sales  4,182 4,252  4,431  4,567 
Revenue  4,530 4,528 4,691 4,821
Recurring EBIT 1,130  1,095 1,168 1,229
Recurring EBITDA 1,375  1,329 1,399 1,465
Net Profit   753 769 842 899
Core EPS (€) 4.82  4.56 4.92 5.22

 

UCB FY Consensus Product Sales Estimates (Median)

In € million 2017a 2018e 2019e 2020e  2021e  2022e  2023e
Cimzia 1,424 1,454 1,515 1,510 1,498 1,429 1,380
Vimpat 976 1,051 1,170 1,261 1,350 1,053 723
Neupro 314 328 347 360 322 266 217
Briviact 87 156 230 296 369 418 475
Keppra 778 740 693 651 608 576 538

 

UCB FY Consensus Earnings Estimates (Median)

In € million 2017a 2018e 2019e 2020e 
Net Sales  4,182 4,269 4,465  4,625 
Revenue  4,530 4,527 4,695 4,870
Recurring EBIT 1,130  1,088 1,173 1,243
Recurring EBITDA  1,375 1,333 1,405 1,480
Net Profit  753  758 811 885
Core EPS (€)  4.82 4.60 4.88 5.29

Downloads:
UCB FY & HY 2018 Consensus (Excel)
UCB FY P&L Consensus (PDF)
UCB FY Product Sales Consensus (PDF)
UCB HY 2018 Consensus (PDF

Last updated: 16 July, 2018



Check out UCB's new IR Apps: 

App Apple Store

App Google Play

 

Disclaimer:

This document has been compiled by Ellinghorst IR Ltd. for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Ellinghorst IR Ltd. gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness. Ellinghorst IR Ltd. has not commented and will not comment on any of the individual financial forecasts used to generate the information contained herein.